Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder
Condition(s):Opioid-use DisorderLast Updated:September 30, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Opioid-use DisorderLast Updated:September 30, 2022Recruiting
Condition(s):Opioid-use DisorderLast Updated:March 24, 2020Withdrawn
Condition(s):Opioid Use DisorderLast Updated:February 3, 2023Recruiting
Condition(s):Opioid Use DisorderLast Updated:March 2, 2023Not yet recruiting
Condition(s):Neonatal Abstinence Syndrome; Neonatal Opiate Withdrawal SyndromeLast Updated:February 11, 2022Completed
Condition(s):Opioid-use DisorderLast Updated:March 9, 2021Completed
Condition(s):Opioid Use DisorderLast Updated:October 14, 2020Withdrawn
Condition(s):Neonatal Abstinence SyndromeLast Updated:September 26, 2017Completed
Condition(s):Opioid-use DisorderLast Updated:October 3, 2022Completed
Condition(s):Moderate to Severe Opioid Use DisorderLast Updated:October 26, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.